Comparability of Biosimilar Filgrastim with Originator Filgrastim: Protein Characterization, Pharmacodynamics, and Pharmacokinetics

BACKGROUND: Biosimilars provide safety, purity, and potency similar to those of a reference biologic product. METHODS: An array of protein analytical techniques was used to compare the physicochemical properties of proposed biosimilar filgrastim (EP2006), US-approved originator filgrastim, and EU-ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Sörgel, Fritz, Schwebig, Arnd, Holzmann, Johann, Prasch, Stefan, Singh, Pritibha, Kinzig, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412827/
https://www.ncbi.nlm.nih.gov/pubmed/25837839
http://dx.doi.org/10.1007/s40259-015-0124-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412827/
https://www.ncbi.nlm.nih.gov/pubmed/25837839
http://dx.doi.org/10.1007/s40259-015-0124-7

Ejemplares similares